Acadia Pharmaceuticals | Marktkapitalisierung



Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 3.05B 502M 2024-12
ALKERMES USD 4.65B 123M 2024-12
Alnylam Pharmaceuticals USD 30.35B 4.96B 2024-12
Biogen USD 22.28B 5.95B 2024-12
BioMarin Pharmaceutical USD 12.53B 867M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Corcept Therapeutics USD 5.28B 444M 2024-12
Cytokinetics USD 5.55B 661M 2024-12
Eisai JPY 1.26T 322.6B 2024-12
Eli Lilly USD 732.87B 109.15B 2024-12
Incyte USD 13.31B 576M 2024-12
Intra Cellular Therapies USD 8.87B 1.14B 2024-12
J&J USD 348.19B 41.93B 2024-12
Moderna USD 16B 9.69B 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Vertex Pharmaceuticals USD 103.71B 16.33B 2024-12



Acadia Pharmaceuticals Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.